High incidence of porokeratosis in renal transplant recipients

British Journal of Dermatology

Volumn 136, Issue 2, 1997, Pages 176-179

  Herranz, P ^a   Pizarro, A ^a   De Lucas, R ^a   Robayna, M G ^a   Rubio, F A ^a   Sanz, A ^a   Contreras, F ^a   Casado, M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; POROKERATOSIS; PREVALENCE; PRIORITY JOURNAL;

EID: 0031047742     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb14891.x     Document Type: Article

References (28)

1. Griffiths WAD, Leigh IM, Marks R. Disorders of keratinization. In: Textbook of Dermatology (Rook A, Wilkinson DS, Ebling FJ eds). 5th edn. Vol 2. Oxford: Blackwell Scientific Publications. 1992: 1388-90.
2. Reed R, Leone, P. Porokeratosis - a mutant clonal keratosis of the epidermis. Arch Dermatol 1970; 101: 340-7.
3. Otsuka F, Umebayahi Y, Watanabe S et al. Porokeratosis large skin lesions are susceptible to skin cancer development: histological and cytological explanation for the susceptibility. J Cancer Res Clin Oncol 1993; 119: 395-400.
4. Chernosky ME, Rapini RP. Squamous cell carcinoma in lesions of disseminated superficial actinic porokeratosis: a report of two cases. Arch Dermatol 1986; 122: 853-5.
5. Gray MH, Smoller BS, McNutt NS. Carcinoogenesis in porokeratosis. Evidence for a role relating to chronic growth activation of keratinocytes. Am J Dermatopathol 1991; 13: 438-44.
6. Lederman JS, Sober AJ, Lederman GS. Immunosuppression: a cause of porokeratosis? J Am Acad Dermatol 1985; 13: 75-9.
7. Bencini PL, Crosti C, Sala F. Porokeratosis: immunosuppression and exposure to sunlight. Br J Dermatol 1987; 116: 113-16.
8. Wilkinson SM, Cartwright PH, English JSC. Porokeratosis of Mibelli and immnnosuppression. Clin Exp Dermatol 1991; 16: 61-2.
9. Manganoni AM, Facchetti F, Gavazzoni R et al. Involvement of epidermal Langerhans cells in porokeratosis of immunosuppressed renal transplant recipients. J Am Acad Dermatol 1989; 21: 799-801.
10. Tatnall FM, Sarkany Y. Porokeratosis of Mibelli in an immunosuppressed patient. J R Soc Med 1987; 80: 180-1.
11. Rothman IL, Wirth PB, Klaus MV. Porokeratosis of Mibelli following heart transplant. Int J Dermatol 1992; 31: 52-4.
12. Kanitakis J, Misery L, Nicolas JF et al. Disseminated superficial porokeratosis in a patient with AIDS. Br J Dermatol 1994; 131: 284-9.
13. Abel EA. Cutaneous manifestations of immunosuppression in organ transplant recipients. J Am Acad Dermatol 1989; 21: 167-79.
14. Euvrard S, Kanitakis, J, Pouteil-Nobel C et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-9.
15. Cohen EB, Komorowski RA, Clowry LJ. Cutaneous complications in renal transplant recipients. Am J Clin Pathol 1987; 88: 32-37.
16. Manganoni AM, Setti G, Gavazzoni R et al. Patologia preneoplastica e neoplastica cutanea in pazienti sottoposti a trapianto renale. G Ital Dermatol Venereol 1991; 126: 35-7.
17. Strumia R, Perini L, Tarroni G et al. Skin lesions in kidney transplant recipients. Nephron 1992; 62: 137-41.
18. Bencini PL, Tarantino A, Grimalt R et al. Porokeratosis and immunosuppression. Br J Dermatol 1995: 132: 74-8.
19. Brown JH, Hutchinson T, Kelly AM, McGeown MG. Dermatologic lesions in a transplant population. Transplantation 1988; 46: 530-2.
20. McLelland J, Rees A, Williams G, Chu T. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 1988; 46: 871-4.
21. Blöhme Y, Larkö O. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy. Acta Derm Venereol (Stockh) 1990; 70: 491-4.
22. Chugh KS, Sharma SC, Singh V et al. Spectrum of dermatological lesions in renal allograft recipients in a tropical environment. Dermatology 1994; 188: 108-12.
23. Tsamboas D, Spiliopoulos T. Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression. J Am Acad Dermatol 1993; 28: 651-2.
24. Gilead L, Guberman D, Zlotogorski A et al. Immunosuppression-induced porokeratosis of Mibelli: complete regression of lesions upon cessation of immunosuppressive therapy. J Eur Acad Dermatol Venereol 1995; 5: 170-2.
25. Zenaola P, Melillo L, Lomuto M et al. Exacerbation of porokeratosis: a sign of immunosuppression. J Am Acad Dermatol 1993; 29: 1035-6.
26. Buthani LK, Kanwar AJ, Singh OP. Porokeratosis of Mibelli with unusual features. Dermatologica 1977; 155: 296-300.
27. Neumann RA, Knobler RM, Gehhart W. Unusual presentation of porokeratosis palmaris, plantaris et disseminata. J Am Acad Dermatol 1989; 21: 1131-3.
28. Dover JS, Phillips TJ, Burns A, Krafchik BR. Disseminated superficial actinic porokeratosis: coexistence with other porokeratotic variants. Arch Dermatol 1986; 122: 887-9.